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Abstract
Previous studies have implicated DTNBP1 as a schizophrenia susceptibility gene and its encoded 
protein, dysbindin, as a potential regulator of synaptic vesicle physiology. In this work, we found 
that endogenous levels of the dysbindin protein in mouse brain are developmentally regulated, 
with higher levels observed during embryonic and early postnatal ages than in young adulthood. 
We obtained biochemical evidence indicating that the bulk of dysbindin from brain exists as a 
stable component of biogenesis of lysosome-related organelles complex-1 (BLOC-1), a multi-
subunit protein complex involved in intracellular membrane trafficking and organelle biogenesis. 
Selective biochemical interaction between brain BLOC-1 and a few members of the SNARE 
superfamily of proteins that control membrane fusion, including SNAP-25 and syntaxin 13, was 
demonstrated. Futhermore, primary hippocampal neurons deficient in BLOC-1 displayed neurite 
outgrowth defects. Taken together, these observations suggest a novel role for the dysbindin-
containing complex, BLOC-1, in neurodevelopment, and provide a framework for considering 
potential effects of allelic variants in DTNBP1 – or in other genes encoding BLOC-1 subunits – in 
the context of the developmental model of schizophrenia pathogenesis.
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Introduction
Schizophrenia is a psychiatric disorder with a prevalence of 0.5–1.0%.1 Although its 
heritability has been estimated to be in the order of 80%, unambiguous identification of 
susceptibility genes has proven to be extremely challenging.2 Nevertheless, several 
candidate genes have emerged and become the subject of intense multidisciplinary research, 
including follow-up genetic studies (e.g., replication attempts in independent patient 
cohorts) and basic experimentation aimed at establishing the “biological plausibility” of the 
proposed genetic association, i.e., whether the function of the gene product would be 
compatible with a role in schizophrenia pathogenesis.1
This paper is devoted to dysbindin, the product of the DTNBP1 gene.3,4 Genetic association 
between haplotype variants within DTNBP1 and increased risk of developing schizophrenia 
stemmed from a family-based study5 that was followed by more than two dozen studies.6,7 
Such genetic association, however, is not unequivocal,8,9 and the possibility remains that 
the impact of DTNBP1 as a schizophrenia susceptibility gene might be restricted to the 
families involved in the initial studies5,10 and/or a rare form of childhood-onset psychosis.
11 Although none of the DTNBP1 variants proposed to increase disease risk would modify 
the amino acid sequence of the encoded dysbindin protein, studies in postmortem brain 
samples have suggested a mechanism whereby these variants would act as cis-elements to 
decrease dysbindin mRNA levels.12–14 Furthermore, a significant reduction in the levels of 
the dysbindin protein was observed in postmortem brain regions from two independent 
cohorts of schizophrenic patients.15 Strikingly, such reduction in protein levels was more 
common among patients (73–93%) than expected from the frequency of the proposed 
susceptibility alleles,15 thus raising the possibility that the involvement of the dysbindin 
protein in the pathogenesis of schizophrenia could be more widespread than anticipated 
from studies that focus on DTNBP1 gene variants.
Recent studies on the sandy mouse line have provided additional support to the notion that 
altered dysbindin function may contribute to the risk of developing schizophrenia. The 
sandy mice, which arose from spontaneous mutation in a DBA/2J stock and carry a Dtnbp1 
allele encoding a protein with an in-frame 22-residue deletion,16 displayed abnormal 
behavioral phenotypes consistent with deficits in social interaction and long-term and 
working memory.17–21 Reduced dopamine levels,17 and abnormalities in synaptic 
morphology and function,22 were also documented. These important findings 
notwithstanding, the function of dysbindin in the brain remains unclear. Although its initial 
description3 as a dystrobrevin-binding protein and a component of the dystrophin-
dystroglycan complex had suggested a postsynaptic site of action, subsequent studies cast 
doubt on the in vivo significance of the dysbindin-dystrobrevin interaction23 and instead 
focused on possible roles for dysbindin at the presynaptic level.15,18,22,24–27 For instance, 
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dysbindin was proposed to regulate synaptic vesicle biogenesis and release,22,24,25 an idea 
consistent with the hypothesis that schizophrenia is primarily a synaptic transmission 
disorder.28 However, another prevailing view is the so-called developmental model of 
schizophrenia pathogenesis, whereby genetic variants contribute with environmental factors 
to a developmental disruption of neural connectivity, embryonically or early in postnatal life 
(e.g., subtle defects in neuronal migration, dendritic arborization or axonal growth) or during 
adolescence (e.g., excessive pruning).1,29,30 To our knowledge, a putative role for 
dysbindin in brain development has not yet been investigated.
In this paper, we report that the dysbindin protein is expressed embryonically in mouse brain 
and is significantly more abundant during embryonic and early postnatal development than 
in adulthood. We also provide evidence that brain dysbindin exists as a stable component of 
BLOC-1 (biogenesis of lysosome-related organelles complex-1), a multi-subunit protein that 
in non-neuronal cells has been implicated in organelle biogenesis and intracellular 
membrane trafficking.31–37 Consistent with a potential role in neurodevelopment, results 
reported herein indicate that BLOC-1 from brain is capable of interacting with a subset of 
SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor)38 proteins 
previously implicated in neurite outgrowth, and that primary hippocampal neurons deficient 
in BLOC-1 display neurite extension defects.
Materials and methods
Information about recombinant proteins, antibodies, animals, primary cell culture, 
preparation of brain tissue extracts and SNARE complexes, and immunoblotting analysis is 
provided as Supplementary materials and methods.
In vitro binding assay
In a typical experiment, frozen bovine brain cytosol (~5 g/l total protein) was quickly 
thawed and diluted with an equal volume of 10 mM Hepes (pH 7.4), 0.15 M KCl, 1 mM 
EGTA, 1 mM dithiothreitol, 0.5 mM MgCl2 and protease inhibitor mixture [1 mM 4-(2-
aminoethyl)-benzenesulfonyl fluoride, 10 mg/l leupeptin, 5 mg/l aprotinin and 1 mg/l 
pepstatin A]. In experiments aimed at testing the ability of cypin to bind BLOC-1, bovine 
brain cytosol was also used with minimal dilution upon addition of EDTA (to 1 mM) and of 
fresh dithiothreitol (1 mM) and protease inhibitor mixture. The diluted cytosol was then 
cleared by ultracentrifugation at 120000 × g for 30 min and/or filtration through a 0.45 μm 
filter (to remove any protein aggregates), and then by incubation with empty Glutathione-
Sepharose 4 Fast Flow beads (GE Healthcare, Piscataway, NJ, USA). Purified glutathione-S-
transferase (GST)-fusion proteins were immobilized on glutathione-Sepharose beads, while 
purified His6-S-tag-fusion proteins and recombinant SNARE complexes were immobilized 
on Protein-S-agarose beads (EMD Biosciences Novagen, Madison, WI, USA); in 
experiments using proteins immobilized on both types of beads, all samples contained a 1:1 
(v/v) bead mixture to achieve comparable levels of non-specific protein binding. The 
immobilized recombinant proteins were then incubated with cleared cytosol at 4°C for at 
least 1 h, after which the beads were washed three times with ice-cold washing buffer (10 
mM Hepes, pH 7.4, 75 mM KCl, 1 mM EGTA, 0.5 mM MgCl2) containing 0.1% (w/v) 
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Triton X-100 and once with the same buffer lacking Triton X-100. Proteins bound to the 
washed beads were eluted by boiling in the presence of SDS-PAGE sample buffer, and 
subsequently analyzed by immunoblotting.
Immunocytochemistry and neurite outgrowth assay
Primary hippocampal neurons (see Supplementary materials and methods) were fixed, 
permeabilized and immunostained with antibodies to GAP43, βIII-tubulin and GFAP, as 
previously described.39 Digital images of randomly selected microscopic fields were 
acquired on a Zeiss Axioskop 2 microscope (Carl Zeiss) equipped with an ORCA-ER digital 
camera (Hamamatsu), using a 40× objective and appropriate filters. The images were saved 
using coded file names to mask the identity of cell samples, such that the person(s) involved 
in subsequent image analysis could not establish the identity of the samples. Image-based 
analysis of neurite number and length was performed using the Carl Zeiss AxioVision 
software. Processes that were shorter than 5 μm were excluded from the analysis.
Statistical analysis
Differences between steady-state protein expression levels were analyzed by regression 
analysis or one-way ANOVA followed by Bonferroni’s multiple comparison tests. For the 
analysis of data resulting from neurite outgrowth experiments, we focused on three measures 
per cell: neurite number, length of the longest neurite, and sum of lengths of all neurites. The 
significance of effects of BLOC-1 deficiency (in the pallid mutant mice) on these measures 
was tested using an ANOVA model in which “genotype” (wild type or pallid) was used as 
explanatory factor together with “days in culture” (1 or 3 days) and “primary culture 
preparation” (four independent preparations using serum-free Tii medium and one using 
DMEM plus serum; see Supplementary Table S1 for details). Mean values per digital image, 
rather than individual values per cell, were analyzed to minimize correlation between 
observations, and data were subjected to logarithmic transformation prior to ANOVA in 
order to make the assumption of Gaussian distributions appropriate. To investigate day-
specific effects, data obtained for cells cultured for 1 or 3 days were analyzed separately, 
keeping genotype and primary culture preparation as the explanatory factors. Only P values 
associated with genotype as a factor are reported. Since several ANOVA tests were 
performed, to evaluate three types of measures and to investigate day-specific effects, the 
significance threshold was lowered to 0.01.
Results
Dysbindin protein levels in the mouse brain are developmentally regulated
To investigate dysbindin protein levels in mouse brain and their possible developmental 
regulation, “whole-tissue” extracts prepared from mouse cerebral cortex at different ages, 
spanning from embryonic day (E)14 through postnatal day (P)45, were analyzed by 
immunoblotting. We used an affinity-purified, rabbit polyclonal antibody against dysbindin 
previously generated and validated.33 The antibody recognized a major protein species with 
an apparent molecular mass of ~50 kDa, a value which is in agreement with previous 
reports.3,15,26 As shown by representative immunoblots (Figure 1a) and quantitative 
analyses (Figure 1b), there was a consistent decline in dysbindin protein levels throughout 
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the age period examined, unlike the roughly constant levels of housekeeping proteins (e.g., 
β-actin) or the dramatic increase in expression exhibited by synaptosomal-associated protein 
(SNAP)-25 and syntaxin 1. Such age-dependent decline in dysbindin protein levels was not 
unique to cerebral cortex; as shown in Figure 2, the average level in hippocampus from P1 
mice was, like in cerebral cortex, more than three times that from P45 mice, and in 
cerebellum from P7 mice it was about twice that in cerebellum from P45 animals. These 
changes remained statistically significant upon normalizing the dysbindin protein level of 
each sample to that of β-actin (data not shown). Since we were concerned that these apparent 
declines in dysbindin abundance could be secondary to differences in cell composition of the 
dissected tissues, specifically due to gliogenesis, purified primary cultures of astrocytes, 
oligodendrocytes and neurons were examined for dysbindin expression. Both types of glial 
cells displayed steady-state levels of dysbindin that were comparable to, if not higher than, 
those detected in neurons (Supplementary Figure S1). Importantly, dysbindin protein levels 
also declined in primary cortical neurons kept in culture for longer than a week 
(Supplementary Figure S1). These results suggested that dysbindin protein expression in 
brain is developmentally regulated, implying a potential role for the protein in embryonic 
and early postnatal development.
Brain dysbindin is a stable component of BLOC-1
To begin to understand which role(s) dysbindin may play during neurodevelopment, it was 
important to address the biochemical properties of the endogenously expressed protein. In 
non-neuronal cells, dysbindin associates into a multi-subunit complex, BLOC-1, which also 
contains the proteins pallidin, muted, cappuccino, snapin and BLOC-1 subunit (BLOS)1, 2 
and 3.16,31–33,40,41 We had previously reported co-immunoprecipitation of endogenous 
dysbindin and pallidin from brain,23 and another group subsequently showed co-
immunoprecipitation of dysbindin and snapin.26 To test whether these results reflected 
transient interactions of monomeric dysbindin with the other two proteins or stable 
association of dysbindin into a brain form of BLOC-1, two sets of experiments were 
performed:
In the first set, the steady-state levels of the dysbindin protein were examined in selected 
brain regions from pallid mutant mice. These mice carry a non-sense mutation in the gene 
encoding pallidin,42 which is essential for BLOC-1 assembly.31,32 We reasoned that 
dysbindin protein levels would be significantly reduced in pallid mouse brain if the protein 
normally existed as a component of BLOC-1 and was biochemically unstable in 
unassembled form. Such is a usual phenomenon for subunits of stable protein complexes, 
and it has been observed for dysbindin from kidney16 and liver.33 As shown in Figure 3, 
panels a and b, drastically reduced levels of the major ~50-kDa species (and, where 
detectable, of two minor species of 42 and 38-kDa) were observed in “whole-tissue” extracts 
prepared from cerebral cortex, hippocampus and cerebellum of P45 pallid mice (Figure 3a), 
as well as from P1 pallid cerebral cortex and hippocampus (Figure 3b), as compared to equal 
total protein loads of the corresponding extracts from wild-type mice. Similar results were 
obtained at other ages (e.g., P7 cerebral cortex, hippocampus and cerebellum; data not 
shown) as well as in primary cultures of hippocampal neurons from P0 mice (Figure 3c).
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In the second set of experiments, detergent-free extracts were prepared from wild-type 
mouse brain, under conditions in which ~90% of dysbindin was recovered in soluble form 
(Figure 3d), and the cytosolic proteins were then fractionated by high-resolution, size-
exclusion chromatography. As shown in Figure 3, panels e and f, the elution profile of 
dysbindin consisted of a single peak corresponding to a Stokes’ radius of 95±5 Å, a native 
molecular size which fits within the error range the one previously reported for BLOC-1 
from mouse liver (~94 Å).33 Moreover, the elution profile of dysbindin was in close match 
with that of pallidin (Figure 3e), and there was little or no dysbindin immunoreactivity in 
fractions corresponding to the size expected for a putative monomeric form, which instead 
contained the monomeric dysbindin-related protein, CK1BP43 (Stokes’ radius 40±2 Å, 
Figure 3f).
Taken together, these results suggested that the bulk of dysbindin from brain exists as a 
stable component of BLOC-1. Consistent with this conclusion, we observed age-dependent 
declines in the steady-state levels of the pallidin subunit from mouse cerebral cortex, 
hippocampus and cerebellum that mirrored those observed for the dysbindin protein (Figure 
2 and data not shown).
Physical interactions between brain BLOC-1 and SNARE proteins
As part of our attempts to understand the function of dysbindin in brain, we investigated 
potential interactions with candidate binding partners that had been previously described for 
isolated BLOC-1 subunits and implicated in neurodevelopment. Specifically, we focused 
our attention onto two members of the large superfamily of SNARE proteins, SNAP-25 and 
syntaxin 13. The SNARE proteins are key regulators of docking and fusion of intracellular 
membranes, including the fusion of vesicles with the plasma membrane during exocytosis.
38 They characteristically contain one or two SNARE homology domains of the R, Qa, Qb 
and Qc types, which can assemble into a tight four-helix bundle containing one copy of each 
SNARE domain type. It is thought that formation of these SNARE complexes brings two 
membranes in close proximity and provides the free energy required to drive fusion (see the 
scheme in Supplementary Figure S2).38 SNAP-25 is best known for its role in synaptic 
vesicle exocytosis,44 but it also has a demonstrated role in membrane fusion events that 
occur during the process of neurite outgrowth.45–47 Syntaxin 13 expression in brain is 
developmentally regulated, and the protein was shown to bind to SNAP-25 and to regulate 
neurite outgrowth.48 We also focused our attention onto cypin, a guanine deaminidase that 
regulates dendrite branching.49 Both SNAP-2550 and cypin51 were reported to bind to 
snapin, while syntaxin 13 was shown to interact with pallidin.42
To evaluate the potential significance of these interactions for dysbindin function, we first 
sought to determine whether any of these proteins could be specifically recognized as a 
binding partner by the intact BLOC-1 isolated from brain. We used an affinity “pulldown” 
assay, whereby recombinant forms of the candidate binding partners were immobilized onto 
beads, and the binding of BLOC-1 from bovine brain cytosol was assessed by 
immunoblotting using our mAb against the pallidin subunit, which is tightly associated into 
the complex and virtually undetectable in free form.32,33 As shown in Figure 4a and 
Supplementary Figure S4, both alternatively spliced variants of SNAP-25 (a and b) robustly 
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interacted with BLOC-1, like SNAP-47 and unlike the related proteins SNAP-23 and -29. 
Besides SNAP-23,52 other proteins reported to interact with snapin but for which we have 
failed to detect any interaction with brain BLOC-1 include cypin and regulator of G protein 
signaling (RGS)7,53 the latter being a paralog of the RGS4 protein encoded by a candidate 
schizophrenia susceptibility gene54 (Supplementary Figure S4). Specific SNAP-25 binding 
was observed not only for BLOC-1 from adult bovine brain but also for the native complex 
from cerebral cortex of P1 and P7 mice (Supplementary Figure S4). Attempts to map the 
BLOC-1-binding interface using truncated SNAP-25 constructs (Figure 4b) suggested that 
the Qb domain and part of the linker region connecting it to the Qc domain are both 
necessary for robust binding to BLOC-1 (Figure 4c). Under the same experimental 
conditions, the Qb SNARE proteins Vti1a and Vti1b failed to interact with BLOC-1 (Figure 
4a), as did the VAMP2 and VAMP7 proteins containing SNARE domains of the R type 
(Figure 4c). We also observed that a recombinant protein comprising the entire cytoplasmic 
region of syntaxin 13 was unable to bind brain BLOC-1 (Figure 4d). However, syntaxin 13 
and other syntaxins characteristically contain an auto-inhibitory helical region, named Habc, 
which binds intramolecularly to the Qa SNARE domain (Figure 4e), thus inducing a 
“closed” conformation.55 We then tested smaller portions of the cytoplasmic region and 
observed binding of BLOC-1 to a syntaxin 13 fragment, referred herein to as SN, which 
included the SNARE Qa domain and lacked the Habc domain (Figure 4d). Similar 
experiments using analogous SN fragments from various syntaxins demonstrated selectivity 
of BLOC-1 binding towards syntaxin 13 and, to a lesser extent, syntaxins 16 and 1 (Figure 
4f).
Because SNARE complexes containing SNAP-25, syntaxin 13 and a VAMP protein have 
been detected in brain,48,56 it was pertinent to ask whether SNARE complex assembly 
would potentiate, or inhibit, the BLOC-1-binding activity. To this end, purified recombinant 
proteins comprising full-length SNAP-25, the cytoplasmic portion of VAMP2, and the SN 
fragment of either syntaxin 1, 4 or 13, were mixed under conditions that allowed formation 
of recombinant SNARE complexes (Figure 5a), which were then purified from unassembled 
subunits by two sequential affinity-purification steps. The recombinant complexes were 
biochemically stable, as judged from the appearance of sodium dodecyl sulfate (SDS)-
resistant species38 upon polyacrylamide gel electrophoresis (Figure 5b, asterisk). Next, the 
abilities of the purified SNARE complexes to bind BLOC-1 from bovine brain cytosol were 
compared to those of the unassembled subunits. As shown in Figure 5c, there was some 
detectable binding of BLOC-1 to recombinant complexes containing SNAP-25, VAMP2 and 
either syntaxin 1 or 13. However, while the extent of BLOC-1 binding to these complexes 
was comparable to that observed for syntaxin 13 alone, it was significantly less than that 
observed for an equivalent molar amount of unassembled SNAP-25. Therefore, BLOC-1 
displays in vitro a preference towards binding to unassembled SNAP-25, and SNARE 
complex assembly impairs BLOC-1 binding.
Conflicting results have been reported concerning the impact of dysbindin protein 
knockdown on SNAP-25 expression levels in cultured cells.24,25 Here, the steady-state 
levels of SNAP-25, as well as its membrane association and assembly into SDS-resistant 
SNARE complexes, were examined and found to be normal in cerebral cortex from pallid 
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mice (Supplementary Figure S5), which as mentioned above displays significantly reduced 
levels of the dysbindin protein (Figure 3a).
Taken together, the above results suggested that brain BLOC-1 is capable of selectively 
recognizing unassembled SNAP-25 and -47 as well as syntaxin 13 (and other syntaxins) in 
open conformation.
Neurite extension defects in primary neurons deficient in BLOC-1
The observed regulation in the levels of the dysbindin protein in brain during development 
(Figures 1 and 2), together with the in vitro interaction between the dysbindin-containing 
complex (BLOC-1) and some SNARE proteins (Figures 4 and 5) implicated in neurite 
outgrowth,45–48,57 prompted us to investigate whether BLOC-1 could play a role in this 
process. To this end, primary neuronal cultures were established from the hippocampus of 
newborn (P0-P1) wild-type and BLOC-1-deficient pallid mice. As mentioned above, 
hippocampal neurons from wild-type mice expressed both pallidin and dysbindin proteins, 
while those from pallid mice were devoid of pallidin and displayed reduced steady-state 
levels of the dysbindin protein (Figure 3c). Next, the ability of these cells to extend neurite 
processes was assessed by morphometric analyses. Representative microscopic images are 
shown in Figure 6a.
Upon one day in culture, hippocampal neurons displayed relatively few neurites (Figure 6a 
and Supplementary Figure S6) and their number was not significantly affected by BLOC-1 
deficiency (P=0.5; Figure 6b). On the other hand, upon three days in culture BLOC-1-
deficient neurons extended an average of 14–20% fewer neurites than control neurons 
(Figure 6b). We then measured neurite lengths, focusing our analysis on the longest neurite 
per cell (Figure 6c and Supplementary Figure S6); here, the effect of BLOC-1 deficiency 
was more evident in cells cultured for one day (~15% decrease, P=0.0004) than in those 
cultured for three days (<10% decrease). We reasoned that these effects could reflect a 
common underlying phenomenon of compromised membrane delivery to the sites of neurite 
outgrowth in the absence of BLOC-1, and hence calculated the sum of lengths of all neurites 
per cell as an indirect estimate of the extent of membrane surface expansion. Interestingly, 
the effect of BLOC-1 deficiency was consistent upon both one day (~12% decrease, 
P=0.0043) and three days (~17% decrease, P=0.0027) in culture (Figure 6d), and the overall 
significance of genotype as an explanatory factor was high for the entire dataset (P<0.0001). 
Consequently, these results revealed a partial but statistically significant deficit in the ability 
of BLOC-1-deficient neurons to extend neurites.
Discussion
We have obtained converging evidence for the stable association of brain dysbindin into 
BLOC-1, and for a potential role of this complex during neurodevelopment. These findings 
provide a new perspective for considering how allelic variations in the dysbindin-encoding 
gene could contribute to the risk of developing schizophrenia. Specifically, while our results 
do not negate proposed mechanisms that involve dysbindin function in the adult brain,
22,24,25,27 a role for BLOC-1 in the regulation of neurite outgrowth is reminiscent of those 
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documented for the products of other candidate susceptibility genes, such as DISC1,58–60 
and fits within the developmental hypothesis of schizophrenia pathogenesis.29,30
Although the original view of dysbindin as a component of the dystrophin-dystroglycan 
complex3 had been challenged a few years ago,15,23 the possibilities of dysbindin existing 
in brain as a monomer, homo-oligomer or assembled into multimeric complexes had not 
been investigated. Our results imply that the biochemically stable form of brain dysbindin 
exists as a subunit of BLOC-1. Although the putative existence of a small pool of insoluble 
dysbindin not assembled into BLOC-1 cannot be completely ruled out, it seems reasonable 
to infer that BLOC-1 represents the main biologically active form of dysbindin in brain. 
Such inference provides a conceptual framework for understanding the normal molecular 
function of dysbindin in brain and how its defects would contribute to the pathogenesis of 
schizophrenia. Simply put: if the biologically active form of dysbindin is the one assembled 
into BLOC-1, then it is the entire complex what should be the focus of molecular and 
functional studies. This view is consistent with a recent report61 of increased schizophrenia 
risk associated with variations in the gene encoding the BLOS3 subunit, and with an 
epistatic interaction between those encoding dysbindin and the muted subunit. These genetic 
variations would contribute to the disease risk by a common mechanism involving reduced 
BLOC-1 expression. Here, we have pursued this idea by examining protein-protein 
interactions involving the entire BLOC-1 from brain, and by using a well-established animal 
model of BLOC-1 deficiency – the pallid – mice for functional studies using primary 
neuronal cultures.
Although at least 70 candidate-binding partners of individual BLOC-1 subunits have been 
identified through yeast-two hybrid analyses,62 the vast majority of them has not been 
tested for their ability to interact with the intact complex. Our finding that the steady-state 
levels of the complex (as judged from those of dysbindin and pallidin) are developmentally 
regulated prompted us to focus on a subset of candidate-binding partners that had been 
implicated in neurodevelopment. We herein report specific in vitro interaction between brain 
BLOC-1 and two types of SNARE proteins: the Qbc SNAREs SNAP-25 and -47, and the 
Qa SNARE syntaxin 13 (as well as syntaxins 16 and 1). Because SNARE proteins assemble 
into heterotypic complexes containing one domain each of the Qa, Qb, Qc and R types,38 it 
follows that pairs of these BLOC-1-binding partners could associate with each other (and 
with an R-type SNARE). In fact, a SNARE complex containing both syntaxin 13 and 
SNAP-25 has been isolated from the developing brain.48 However, our binding analyses 
indicate that SNARE complex assembly severely impairs BLOC-1 binding, arguing for a 
potential regulatory role of BLOC-1 during early stages in the SNARE complex assembly 
process (see model in Supplementary Figure S2).
The observed interactions between BLOC-1 and SNARE proteins provide a plausible 
mechanism by which BLOC-1 could regulate neurite outgrowth. While the function of 
SNAP-47 remains obscure,63 other SNAREs that are capable of binding BLOC-1 have been 
implicated in – among other cellular functions – the delivery of membranes from an 
intracellular compartment to the growth cone.45–48,57 It is worth mentioning that an 
endosomal compartment, referred to as the cell outgrowth secretory endosome,64 is 
considered an important source of intracellular membranes for surface expansion during 
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neurite outgrowth, and that BLOC-1,34 syntaxin 1356,65 and a small pool of SNAP-2547 
have been localized to endosomes, at least in certain cell types. A regulatory role for 
BLOC-1 in the delivery of endosomal membranes to sites of neurite outgrowth would be 
compatible with the results of our morphometric analyses of BLOC-1-deficient neurons, 
which displayed the most consistent differences from wild-type neurons when a surrogate of 
total surface expansion was measured. However, alternative molecular mechanisms cannot 
be excluded at this point. Besides, the expression of dysbindin in oligodendrocytes and 
astrocytes (Supplementary Figure S1) raises the possibility that the function of BLOC-1 in 
brain may not be restricted to that exerted in neurons. Future work will be required to 
address these points.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Developmental regulation of dysbindin protein level in mouse cerebral cortex. (a) 
Immunoblotting analysis of “whole-tissue” detergent extracts (20 μg total protein) prepared 
from cerebral cortices dissected out of C57BL/6J mice at embryonic day (E)14 and E18 and 
postnatal day (P)1 through P45. (b) Quantitative analyses of the relative expression levels of 
selected proteins in cortex from mice at different developmental ages. Each value derived 
from densitometric analysis was corrected for background and divided by the sum of values 
obtained in the same immunoblot image for one sample each of P1, P7, P14 and P21. For 
the sake of clarity, data are represented as means ± s.e.m. (2–4 independent samples per 
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age), even when all data points were analyzed together by linear regression to assess 
departure from a theoretical line with slope equal to zero (18 degrees of freedom; dysbindin, 
P < 0.001; β-actin, not significant).
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Figure 2. 
Dysbindin and pallidin protein levels are higher in the cerebral cortex and hippocampus 
(Hippo.) of C57BL/6J mice at postnatal day (P)1, and in cerebellum (Cerebell.) from P7 
mice, than in the corresponding brain regions of young adult (P45) mice. “Whole-tissue” 
detergent extracts were analyzed by immunoblotting using antibodies against the indicated 
proteins. The immunoreactivity signals derived from densitometric analysis were corrected 
for background and expressed as a ratio to the sum of background-corrected signals obtained 
in the same immunoblot for one sample each of the three brain regions of P45 mice. Each 
bar represents mean value ± s.e.m. of 4–5 independent brain samples. One-way ANOVA 
followed by Bonferroni’s multiple comparison tests: ** P < 0.01, *** P < 0.001, ns, not 
significant.
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Figure 3. 
Evidence for the existence of brain dysbindin as a stable component of BLOC-1. (a, b) The 
steady-state protein levels of dysbindin are significantly decreased in brain from BLOC-1-
deficient, pallid (pa) mutant mice. “Whole-tissue” detergent extracts were prepared from 
cerebral cortex, hippocampus and cerebellum dissected from mice at postnatal day (P)45 (a), 
and from cerebral cortex and hippocampus dissected from P1 mice (b), and then analyzed by 
immunoblotting using antibodies against the indicated proteins. Besides the major ~50-kDa 
dysbindin form, minor species of ~42 and ~38 kDa were detected. (c) Reductions in 
dysbindin protein levels at steady state were also noted in primary hippocampal neurons 
from pallid mice cultured in Tii medium for 1 or 3 days. (d) Mouse brains were 
homogenized in the absence of detergents, and the homogenates subjected to 
ultracentrifugation to obtain a soluble protein fraction and a membrane pellet. Notice that 
the bulk of dysbindin was recovered from the soluble fraction. (e, f) Soluble protein 
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fractions prepared from P7 brain (e) and adult brain (f) were further fractionated by size-
exclusion chromatography, and the resulting fractions were analyzed by immunoblotting 
using antibodies to dysbindin, pallidin, and a monomeric dysbindin-related protein named 
CK1BP. The exclusion volume (Vo) and elution positions of proteins with known Stokes’ 
radii (in Angstroms) are indicated on the top. The elution profile of dysbindin, consisting of 
a peak corresponding to large Stokes’ radii (95±5 Å, arrowheads), was in close match to 
that of pallidin (e) and drastically different from that of CK1BP (f).
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Figure 4. 
Interaction of brain BLOC-1 with recombinant SNARE proteins. (a, c, d, f) Purified GST-
fusion proteins were immobilized on glutathione-Sepharose beads and incubated with 
bovine brain cytosol. Following extensive washing, bound proteins were eluted from beads 
and analyzed by immunoblotting using a mAb against the pallidin subunit of BLOC-1. 
Aliquots of the cytosolic extract, corresponding to 0.1–3% of the total amount incubated 
with each GST-fusion protein, were analyzed in parallel. (a) Both SNAP-25a and -25b 
interacted robustly with BLOC-1 under conditions in which SNAP-23 and -29, as well as the 
cytoplasmic regions (cyt) of the Qb SNAREs Vti1a and Vti1b, failed to bind detectable 
amounts of the complex. (b) Schematic representation of the SNAP-25b protein, which 
contains the SNARE domains Qb and Qc separated by a linker region. (c) Both the Qb 
domain and a portion of the linker, but not the Qc domain, were necessary for robust binding 
of SNAP-25b to BLOC-1. No BLOC-1-binding activity was observed for recombinant 
proteins bearing the cytoplasmic regions of SNARE proteins of the VAMP family. (e) 
Schematic representation of the syntaxin 13 protein, which contains an auto-inhibitory Habc 
domain, a Qa SNARE domain and a transmembrane (TM) region. (d, f) The SN fragment of 
syntaxin 13, but not the entire cytoplasmic fragment containing the Habc domain, interacted 
selectively with BLOC-1. SDS-PAGE analyses of all recombinant proteins used in these 
experiments are shown in Supplementary Figure S3.
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Figure 5. 
SNARE complex assembly impairs BLOC-1 binding. (a) Schematic representation of 
recombinant proteins used to assemble a Qa/Qb/Qc/R SNARE domain complex consisting 
of full-length SNAP-25b, the cytoplasmic region of VAMP2, and the SNARE domain 
region of various syntaxins. The GST and His6-S (His) tags are depicted out of scale. (b) 
SDS-PAGE analysis of recombinant proteins used for the binding assay, including SNARE 
complexes containing SNAP-25b, the cytoplasmic region of VAMP2 and fragments of 
syntaxins 1, 4 or 13 (numbered arrows). The amounts of loaded proteins correspond to those 
used for the binding assay. Notice the presence of slow-migrating species (asterisk) in 
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aliquots of the complexes that were processed for SDS-PAGE without boiling to reveal the 
existence of SDS-resistant SNARE complexes. (c) The purified SNARE complexes, 
unassembled SNAP-25b corresponding to 25–100% of the amount incorporated into the 
complexes, and additional control proteins were immobilized on affinity beads and 
incubated with bovine brain cytosol. Proteins in the washed beads, as well as aliquots of the 
cytosol, were analyzed by immunoblotting using a mAb against the pallidin subunit of 
BLOC-1. Notice that the amounts of BLOC-1 bound to SNARE complexes were 
significantly less than that bound to unassembled SNAP-25b.
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Figure 6. 
Absence of BLOC-1 results in neurite outgrowth defects in hippocampal neurons. (a) 
Representative images of primary hippocampal neurons cultured from wild-type (C57BL/6J) 
and BLOC-1-deficient (pallid) mice in Tii medium for 1 or 3 days. Cells were fixed in 4% 
(w/v) paraformaldehyde and stained with antibodies against GAP43 (red). DAPI staining 
was used to label the cell nuclei (blue). Corresponding phase images are shown. Astrocytes 
are denoted with “A”. Bars, 50 μm. (b–d) Primary hippocampal neurons were grown in Tii 
medium (circles) or DMEM medium plus serum (triangles). The number of neurites (b), 
length of the longest neurite (c) and sum of the lengths of all neurites (d) per neuron were 
analyzed using a blinded approach. Each pair of symbols connected by a line represents the 
median values of 15–64 randomly selected images analyzed for wild-type (empty symbols) 
and pallid mutant (filled symbols) cells in each independent preparation. See Supplementary 
Table S1 and Figure S6 for further details. Statistical significance was assessed using an 
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ANOVA model as described under Materials and methods. ** P < 0.01, *** P < 0.001, ns, 
not significant.
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